These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9034638)

  • 21. The effects of nifekalant hydrochloride on the QT dispersion after direct-current defibrillation.
    Maeda K; Takagi M; Tatsumi H; Nakagawa E; Yoshiyama M
    Osaka City Med J; 2008 Jun; 54(1):11-9. PubMed ID: 18819261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
    Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF
    Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction.
    Perkiömäki JS; Koistinen MJ; Yli-Mäyry S; Huikuri HV
    J Am Coll Cardiol; 1995 Jul; 26(1):174-9. PubMed ID: 7797747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
    Cairns JA; Connolly SJ; Roberts R; Gent M
    Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease.
    Zareba W; Moss AJ; le Cessie S
    Am J Cardiol; 1994 Sep; 74(6):550-3. PubMed ID: 8074036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
    Piccini JP; Schulte PJ; Pieper KS; Mehta RH; White HD; Van de Werf F; Ardissino D; Califf RM; Granger CB; Ohman EM; Alexander JH
    Crit Care Med; 2011 Jan; 39(1):78-83. PubMed ID: 20959785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QT interval dispersion as a predictor of arrhythmic events in congestive heart failure. Importance of aetiology.
    Galinier M; Vialette JC; Fourcade J; Cabrol P; Dongay B; Massabuau P; Boveda S; Doazan JP; Fauvel JM; Bounhoure JP
    Eur Heart J; 1998 Jul; 19(7):1054-62. PubMed ID: 9717041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarrhythmic drug effects on QT interval dispersion in patients undergoing electropharmacologic testing for ventricular tachycardia and fibrillation.
    Gillis AM; Traboulsi M; Hii JT; Wyse DG; Duff HJ; McDonald M; Mitchell LB
    Am J Cardiol; 1998 Mar; 81(5):588-93. PubMed ID: 9514455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The imprecision in heart rate correction may lead to artificial observations of drug induced QT interval changes.
    Malik M
    Pacing Clin Electrophysiol; 2002 Feb; 25(2):209-16. PubMed ID: 11915990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients With Coronary Heart Disease.
    Viskin S; Chorin E; Viskin D; Hochstadt A; Halkin A; Tovia-Brodie O; Lee JK; Asher E; Laish-Farkash A; Amit G; Havakuk O; Belhassen B; Rosso R
    Circulation; 2019 May; 139(20):2304-2314. PubMed ID: 30696267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death.
    Buja G; Miorelli M; Turrini P; Melacini P; Nava A
    Am J Cardiol; 1993 Oct; 72(12):973-6. PubMed ID: 8213559
    [No Abstract]   [Full Text] [Related]  

  • 33. Amiodarone therapy for sustained ventricular tachycardia after myocardial infarction: long-term follow-up, risk assessment and predictive value of programmed ventricular stimulation.
    Maury P; Zimmermann M; Metzger J; Reynard C; Dorsaz P; Adamec R
    Int J Cardiol; 2000; 76(2-3):199-210. PubMed ID: 11104875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QT as a predictor of recurrence after atrial fibrillation ablation and the impact of amiodarone: results from the placebo-controlled AMIO-CAT trial.
    Diederichsen SZ; Darkner S; Chen X; Johannessen A; Pehrson S; Hansen J; Svendsen JH
    Europace; 2019 Jul; 21(7):1055-1062. PubMed ID: 30843038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise-induced changes in the QT interval duration and dispersion in patients with sudden cardiac death after myocardial infarction.
    Yi G; Crook R; Guo XH; Staunton A; Camm AJ; Malik M
    Int J Cardiol; 1998 Feb; 63(3):271-9. PubMed ID: 9578355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The QTc interval and its dispersion in hypertrophic myocardiopathy--its relation to complex ventricular arrhythmias and the effect of anti-arrhythmia agents].
    Sousa MJ; Aranha J; Cotrim C; Sousa L; Sequeira A; Soares RM; Abreu J; Bernardes L; Gracias R; Salomão S
    Rev Port Cardiol; 1995 Jun; 14(6):461-7, 447-8. PubMed ID: 7662385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome.
    Castro Hevia J; Antzelevitch C; Tornés Bárzaga F; Dorantes Sánchez M; Dorticós Balea F; Zayas Molina R; Quiñones Pérez MA; Fayad Rodríguez Y
    J Am Coll Cardiol; 2006 May; 47(9):1828-34. PubMed ID: 16682308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dispersion of QT interval in premature ventricular beats as a marker of susceptibility to arrhythmic events.
    Dabrowski A; Kramarz E; Piotrowicz R
    J Cardiovasc Risk; 1998 Apr; 5(2):97-101. PubMed ID: 9821062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease.
    Brugada J; Brugada R; Brugada P
    Circulation; 1998 Feb; 97(5):457-60. PubMed ID: 9490240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of ventricular repolarisation inhomogeneity after aortic bileaflet valve replacement in patients with aortic stenosis.
    Tsai CH; Lee TM; Su SF
    Int J Cardiol; 1999 Jul; 70(2):141-8. PubMed ID: 10454302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.